Steglujan 5 mg /100 mg

Steglujan 5 mg /100 mg is a medicine authorised by Swissmedic under authorisation number 66578. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 October 2018 and the authorisation is valid without a time limit. ATC code A10BD24 places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 66578
  • ATC A10BD24
  • Synthetic medicines
Authorisation data
Authorisation number66578
NameSteglujan 5 mg /100 mg
Full nameSteglujan 5 mg /100 mg, Filmtabletten
Authorisation holderMSD Merck Sharp & Dohme AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA10BD24
First authorisation18 October 2018
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
2Steglujan 5 mg /100 mg, FilmtablettenB18 October 2018

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
328Tablette(n)A10BD2407.06.2.B
498Tablette(n)A10BD2407.06.2.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Steglujan 5 mg /100 mg authorised in Switzerland?

Yes. Steglujan 5 mg /100 mg is authorised by Swissmedic under authorisation number 66578, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Steglujan 5 mg /100 mg have?

Steglujan 5 mg /100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Steglujan 5 mg /100 mg?

The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com